Change in CFO
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova has announced a CFO change effective May 22-23, 2026. Mr. Arun Kumar Sharma stepped down as CFO and will now serve as Advisor to the Chairmen. The Board has appointed Mr. Ashish Mukkirwar as the new CFO and Key Managerial Personnel starting May 23, 2026. Ashish Mukkirwar joins from Glenmark Pharmaceuticals where he served as Group Vice President & CFO - Global Formulations Business, bringing over two decades of experience in corporate finance, M&A, and investor relations from firms including Moelis & Company and UBS Investment Banking. The Board expressed appreciation for Arun Kumar Sharma's contributions during his tenure.
This is a routine executive transition as the outgoing CFO moves to an advisory role internally. The appointment of an experienced external candidate with pharmaceutical industry experience and investment banking background may be viewed positively by investors. No immediate impact on operations expected.